A public record of an unfinished emergency

They declared
the emergency over.
Millions are still
living it.

Long COVID can disable anyone. There is no approved treatment for the disease itself and no established cure. Patients are being asked to survive a mass-disabling illness with symptom management, improvisation, and waiting.

Enter the record
Watch the full story

The treatment gap · verified July 2026

0

FDA-approved drugs specifically for Long COVID

CDC says there are no approved treatments. Current care focuses on managing symptoms and associated conditions. That is not a cure.

Verify at CDC Read the FDA report
01

How to use this record

The human record

What the numbers
cannot hold

The people with the least energy to be visible are placed first: severe and bedbound patients, children who lost school, and families forced to become full-time care systems.

Long COVID and ME/CFS left the science creator bedbound and dependent on full-time care; her husband documents the reality of severe illness and slow, uneven change.

Once intensely active, Sawyer became entirely bedbound with POTS and other disabling symptoms, with standing alone driving a dramatic heart-rate rise.

Bedbound illness exposed the distance between public ideas of recovery and the intimate reality of being unable to sit up, socialize, or work.

At 24, the level of care she needed was so great that residential care was discussed—a stark mismatch between her age and the systems available.

At 18, severe Long COVID replaced school, friendships, independence, and the start of adult life with bedbound illness and dependence on family care.

After a mild initial infection, light exercise triggered a relapse that left the previously athletic teenager bedbound for the next eight months.

Bedridden for three months, she was too ill to talk, read, watch television, or listen to music. Her teenage son cared for her and his two sick younger brothers.

Travel to medical appointments can make her sicker for weeks. After advice to push through symptoms accelerated her decline, she could walk only two minutes at a time.

Doctors framed severe illness as anxiety and prescribed daily treadmill exercise despite post-exertional crashes. She is now mostly bedbound.

Severe gastrointestinal illness left her able to tolerate only chicken broth and caused a 40-pound weight loss, yet multiple emergency rooms dismissed her without treatment.

At her worst she could not move, speak, or turn her head. Trips between bed, bathroom, and couch ended in collapse, while family members picked her up from the floor.

After clinicians misread severe physical symptoms, she was involuntarily committed. The ordeal left her virtually unable to eat, move, or talk for days.

Curated for lived experience, not virality. Entries are short editorial summaries of public posts, videos, testimony, community writing, and reported profiles. Open each source for the person’s full account. Reddit contributors are anonymized here even when their usernames are public.

Bodies trained for the impossible

Fitness was not
protection.

Long COVID does not only find people already considered vulnerable. It can create vulnerability—ending careers built on exceptional strength, speed, coordination, and endurance.

85Professional tennis

Tanysha Dissanayake

A former top-ranked junior and Wimbledon competitor retired at 21 after becoming largely housebound and needing a wheelchair outside the home.

Sky Sports
86Team GB rowing

Oonagh Cousins

An Olympic rowing dream was derailed when a body trained for extreme endurance could no longer recover from ordinary exertion.

Sky Sports
87Professional running

Drew Hunter

Long COVID interrupted elite training and contributed to a reduced sponsorship contract as performance became less predictable.

The Sick Times
88Steeplechase

Jordan Mann

The pace and mileage once required for an Olympic-trials campaign became impossible to reach safely after infection.

The Sick Times
89Olympic skeleton and athletics

Nathan Ikon Crumpton

A two-time Olympian confronted persistent illness in a career built around marginal gains and absolute trust in physical capacity.

The Sick Times
90Canadian national rowing

Liam Keane

The athlete's instinct to push through pain collided with an illness in which exceeding the limit can make the next day—or week—worse.

The Sick Times
91Olympic canoe slalom

Luuka Jones

Long COVID forced a year away from the sport before a careful return that ultimately led to a fifth Olympic Games.

Reuters
92Paralympic triathlon

Lauren Steadman

A medal-winning triathlete had to rebuild around fatigue and uncertainty rather than the dependable training response elite sport requires.

SELF
93Triathlon

Gráinne Kelly

Long COVID damaged training capacity and daily functioning, showing how far the condition can reach beyond race day.

Patient Worthy
94Professional tennis

Maia Lumsden

Illness kept the British player away from competition for an extended period before an uncertain return to the tour.

The Independent
95800-metre running

Selina Rutz-Büchel

The two-time European indoor champion ended her professional career after Long COVID prevented a return to elite performance.

Canadian Running
96NHL hockey

Brandon Sutter

A veteran player missed an entire season while struggling with symptoms that resisted the normal logic of conditioning and comeback.

The Guardian
97WNBA basketball

Asia Durr

The professional guard described being bedridden, losing more than 30 pounds, and finding simple household chores difficult.

The Washington Post
98College football

Justin Foster

A Clemson defensive end retired after chest pain and breathlessness made even a routine shopping trip physically punishing.

The Washington Post
99Middle-distance running

Rebecca Mehra

Returning to elite running required accepting a nonlinear comeback and treating rest as part of survival rather than a failure of discipline.

Oiselle
100NHL hockey

Jonathan Toews

Persistent symptoms sidelined the longtime Blackhawks captain and complicated whether, and when, an elite career could continue.

ESPN

Elite athletes are not more deserving of care than anyone else. Their stories make one narrow point visible: extraordinary pre-infection fitness does not confer immunity from post-viral disability.

When private loss becomes public data

The damage leaves
an economic trace.

Two broad labor-market signals rose after 2020. They are consistent with a larger burden of chronic illness, but they are not proof that Long COVID caused every additional case. Below them, major studies estimate part of the cost more directly.

Civilian noninstitutional population, age 16+, annual average

U.S. adults reporting a disability

+4.9 million since 2019
2019202020212022202320242025
30.4millions of people35.3

This broad measure includes disability from every cause. Population aging, reporting, other illnesses, and survey effects also matter; it is not a Long COVID count.

Source: BLS Current Population Survey via FRED

People age 16–64 whose main reason for economic inactivity is long-term sickness

UK workers inactive through long-term sickness

+749,000 since 2019
2019202020212022202320242025
2.05millions of people2.79

This series covers all long-term sickness, not Long COVID alone. ONS says the causes of the post-2020 rise are not fully understood.

Source: UK Office for National Statistics, Labour Force Survey
Selected economic-impact studies

Different countries, populations, timeframes, and methods. Read as a range of evidence—not a single pooled estimate.

Correlation is not attribution. Disability surveys, benefits systems, and sickness statistics measure different populations and respond to aging, policy, health-care access, other diseases, and reporting changes. They should prompt investigation—not be used as a shortcut around it.

The scientific record

The evidence
kept arriving.

Twenty-five influential studies and frameworks that named the condition, measured its scale, documented its biology, and changed the policy argument.

012020 · JAMAPersistent Symptoms in Patients After Acute COVID-19Carfì et al.One of the first widely cited clinical reports showing symptoms persisting after hospital discharge.Scale022020 · BMJManagement of post-acute covid-19 in primary careGreenhalgh et al.Gave clinicians an early framework for recognizing and caring for people who were not recovering.Action032021 · Social Science & MedicineHow and why patients made Long CovidCallard & PeregoDocumented how patients used online networks to name the illness and force it into medicine and policy.Naming042021 · Nature MedicineAttributes and predictors of long COVIDSudre et al.Used prospective app data to characterize duration and early predictors in thousands of people.Scale052021 · The Lancet6-month consequences of COVID-19 in patients discharged from hospitalHuang et al.The landmark Wuhan follow-up made long-term disability impossible to ignore.Scale062021 · Nature MedicinePost-acute COVID-19 syndromeNalbandian et al.Synthesized a multisystem clinical framework and helped define a field of care.Naming072021 · NatureHigh-dimensional characterization of post-acute sequelae of COVID-19Al-Aly et al.Mapped six-month health loss across organ systems in national Veterans Affairs data.Damage082021 · EClinicalMedicineCharacterizing long COVID in an international cohort: 7 months of symptoms and their impactDavis et al.Patient-led research catalogued 203 symptoms and quantified work loss, relapses, and multisystem disease.Naming092022 · The Lancet Infectious DiseasesA clinical case definition of post-COVID-19 condition by a Delphi consensusSoriano et al.Created the WHO consensus definition used across health systems and research.Naming102022 · CellMultiple early factors anticipate post-acute COVID-19 sequelaeSu et al.Connected later illness with viral RNA, autoantibodies, Epstein–Barr virus reactivation, and diabetes.Mechanisms112022 · Nature ImmunologyImmunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infectionPhetsouphanh et al.Showed persistent immune activation after infections that were not initially severe.Mechanisms122022 · Nature CommunicationsImmunoglobulin signature predicts risk of post-acute COVID-19 syndromeCervia-Hasler et al.Proposed and independently validated an early immune-and-clinical risk signature.Mechanisms132022 · Nature MedicineLong-term cardiovascular outcomes of COVID-19Xie et al.Quantified substantial one-year cardiovascular risk, including after non-hospitalized infections.Damage142022 · NatureSARS-CoV-2 is associated with changes in brain structure in UK BiobankDouaud et al.Used before-and-after brain imaging to detect structural and cognitive changes following infection.Damage152022 · The LancetPersistence of somatic symptoms after COVID-19 in the NetherlandsBallering et al.Compared symptoms with pre-infection baselines and matched controls across a large population cohort.Scale162022 · JAMAEstimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom ClustersGBD Long COVID CollaboratorsProduced a major global burden estimate and exposed disparities by sex, age, and hospitalization.Scale172022 · Nature MedicineAcute and postacute sequelae associated with SARS-CoV-2 reinfectionBowe et al.Showed additional infections add risk, strengthening the case for reinfection prevention.Action182022 · Nature MedicineLong-term neurologic outcomes of COVID-19Xu et al.Measured increased one-year risks across cognition, nerves, movement, sensory, and cerebrovascular disorders.Damage192022 · NatureSARS-CoV-2 infection and persistence in the human body and brain at autopsyStein et al.Demonstrated wide tissue distribution and RNA persistence for months in some severe cases.Mechanisms202023 · Nature Reviews MicrobiologyLong COVID: major findings, mechanisms and recommendationsDavis et al.A patient-informed synthesis that became a central map of the field and its research priorities.Action212023 · JAMADevelopment of a Definition of Postacute Sequelae of SARS-CoV-2 InfectionThaweethai et al.RECOVER investigators proposed a symptom-based research rule for classifying PASC.Naming222023 · The Lancet Infectious DiseasesOutpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 monthsBramante et al.A randomized trial found early metformin reduced later long-COVID diagnoses, opening a prevention path.Action232023 · NatureDistinguishing features of long COVID identified through immune profilingKlein et al.Identified immune, viral-reactivation, and hormonal features associated with long COVID.Mechanisms242021 · Cardiovascular DiabetologyPersistent clotting protein pathology in Long COVID/PASC is accompanied by increased levels of antiplasminPretorius et al.Advanced the microclot hypothesis and triggered major research and public debate.Mechanisms252024 · Nature MedicineLong COVID science, research and policyAl-Aly et al.Integrated the science with the global economic burden and a policy roadmap for the next phase.Action

“Influential” is an editorial judgment based on field-shaping impact, citation visibility, policy relevance, and representation across the research arc—not a formal citation ranking.

The record requires a response

Evidence without
action is abandonment.

Listen to patients. Fund ambitious biomedical research. Prevent repeat infections. Protect disabled people. Build care that does not require proving the same illness over and over.